Regulating Human Embryonic Stem Cell in China

A Comparative Study on Human Embryonic Stem Cell’s Patentability and Morality in US and EU

Li Jiang (Autor)

Buch | Softcover

200 Seiten

2018 | Softcover reprint of the original 1st ed. 2016
Springer Verlag, Singapore
978-981-10-9528-3 (ISBN)

Artikel merken

The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal funding control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime.
The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonicstem cell research.

Li Jiang is currently a lecturer in Kenneth Wang School of Law, Soochow University. Born in China, Li Jiang was educated at Shandong University, China and graduated with a Bachelors degree in Biotechnology. Li Jiang gained her PhD degree at Bangor University Law School in 2014. Jiang’s research looks at the scope of patentability in respect of the application of the moral exclusion to human embryonic stem cell research through a comparative analysis of the diverging interpretations which have emerged in the regulations of US, EU and China. Many pieces of Jiang’s work have been published by leading international journals in Australia and the United States.

Values of Human Embryonic Stem Cell Research, the phenomenon of “Stem Cell Tourism” and Inadequate regulation of Human Embryonic Stem Cell in China.- The Moral Maze In Human Embryonic Stem Cell Research: the moral status of human embryo and the moral source of human embryonic stem cell.- China: inconsistent moral standards of human embryonic stem cell research between patent law and practical application.- The United States: Inconsistent policies on federal funding control of human embryonic stem cell research.- The European Union: Inconsistent interpretations of moral provisions in Patent Convention addressing human embryonic stem cell research.- A proposal for controlling human embryonic stem cell research in China: regulate research itself in a reconciled human embryonic stem cell regulation at the international regime.

Erscheinungsdatum	02.09.2018
Zusatzinfo	2 Illustrations, black and white; XVIII, 200 p. 2 illus.
Verlagsort	Singapore
Sprache	englisch
Maße	155 x 235 mm
Themenwelt	Geisteswissenschaften ► Philosophie ► Ethik
	Naturwissenschaften ► Biologie
	Recht / Steuern ► EU / Internationales Recht
	Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medienrecht
	Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht
Schlagworte	harmonization • human embryonic stem cell • Legal Diversity • Legal Inconsistency • Legal status of human embryo • Morality of human embryo • Reconciliation • Stem Cell Therapy in China • Stem Cell Tourism Phenomenon • The Patentability Human Embryonic Stem Cell
ISBN-10	981-10-9528-0 / 9811095280
ISBN-13	978-981-10-9528-3 / 9789811095283
Zustand	Neuware